|
楼主 |
发表于 2011-12-18 20:14:02
|
显示全部楼层
来自: 中国广东深圳
又收到古巴方的回复了
CimaVax EGF Vaccine for patients diagnosed with lung cancer.The objectives of the CIMAVAX EGF therapeutic vaccine are:1. Extend the patient's life and improve their quality. (The vaccine is notcurative. The vaccine enhances the effect of chemotherapy and/or radiotherapy 2. Convert this cancer illness in a controlled chronic inflammatory disease None reported serious side effects so farCimaVax EGF vaccine is indicated for patients diagnosed with lung cancer smallcell no cytological confirmation and / or histological stage IIIB or IV, whohave completed the first line treatment of chemotherapy or chemotherapy andradiotherapy.The patient has to stop treatment with chemotherapy. The vaccine iscomplementary, not substitute for specific cancer treatments.Four weeks after completing the first treatment cycle and before the eighthweek, should be assessed objective response to treatment with computerizedaxial tomography studies and / or magnetic resonance imaging and patientclassified as stable disease, partial or total remission.From a functional point of view should be hematological parameters withinnormal limits and a life expectancy of at least 3 months and carries no brainmetastases.At the end of treatment, the patient must submit a summary of your medicalrecords with objective response to treatment (if the tumor increased in size,if the tumor size remained the same, or if decreased size), date of completionof treatment.The patients in disease progression are not an adequate response to treatment.Summary of medical documents with the requested information must be made by thepatient's attending physician on the same date and be followed by the expressrequest of the vaccine treatment.The vaccine treatment is performed in two phases, the first 5 days of lifetakes place in Cuba and the second phase in the country of residence of thepatient, which must acquire appropriate immunizations in Cuba, to conclude amonth of treatment.At the end of treatment, the patient should be contrasted computed tomography,chest radiography, anterior, posterior and lateral abdominal ultrasonography todefine therapeutic continuit Our specialists are the ones who decide whether a patient is a tributary of thevaccine or not. The estimated price of a medical Program is 7200 CUC, which includesaccommodations at the International Health Center "La Pradera", food, airporttransfers, medical consultation and treatment with CIMAVAX, and facilities fora companion. |
|